about
Molecular Interactions in Organic Nanoparticles for Phototheranostic ApplicationsTargeting SR-BI for Cancer Diagnostics, Imaging and TherapyPhototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.Assessing the barriers to image-guided drug delivery.Feature issue introduction: biophotonic materials and applications.Low-density lipoprotein reconstituted by pyropheophorbide cholesteryl oleate as target-specific photosensitizer.Using molecular beacons for cancer imaging and treatment.One minute, sub-one-watt photothermal tumor ablation using porphysomes, intrinsic multifunctional nanovesiclesLow-density lipoprotein nanoparticles as magnetic resonance imaging contrast agentsEvaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivoAn MRI-sensitive, non-photobleachable porphysome photothermal agent.Multimodal bacteriochlorophyll theranostic agent.Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer.Nano-enabled SERS reporting photosensitizers.Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation.Porphyrin Nanodroplets: Sub-micrometer Ultrasound and Photoacoustic Contrast Imaging Agents.Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy.Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging.Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly.Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.Killer beacons for combined cancer imaging and therapy.Biologically-targeted detection of primary and micro-metastatic ovarian cancerPhotodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.Activatable photosensitizers for imaging and therapy.Peptide-based molecular beacons for cancer imaging and therapy.Lipoprotein-inspired nanoparticles for cancer theranosticsFlexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides.Engineering multifunctional nanoparticles: all-in-one versus one-for-all.Lipid-based nanoparticles in the systemic delivery of siRNA.Learning from biology: synthetic lipoproteins for drug delivery.Theranostic lipid nanoparticles for cancer medicine.Non-invasive Macrophage Tracking Using Novel Porphysome Nanoparticles in the Post-myocardial Infarction Murine Heart.Mimicking nature's nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery.Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy.Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage.Organized Aggregation of Porphyrins in Lipid Bilayers for Third Harmonic Generation Microscopy.
P50
Q26798394-DC409AE6-F533-4424-A888-9DD26D4DCECBQ28066708-688B98C2-60B3-4241-9458-1A0590D53FD5Q30395878-7D96B90F-041D-4813-B071-0AA3974F436DQ30422169-90814551-F03E-4214-AA11-1D178E8D6E12Q30489387-682B5755-5985-4EFA-A2AF-44BC1DCCEF2AQ30708656-4F1774B7-8EEA-4A0B-ABCE-376C6F4DA3A3Q33283917-AF0053BE-3AC9-4704-9436-02CD21C27BB3Q35003971-F1F48A4E-03FD-4397-95DC-68822AFFBDF2Q35082176-D94123E2-CC10-4424-9D00-0D901F04D78EQ35109525-15903FAD-AD0B-47B5-8437-74D84FBF5E8DQ35170787-45919A16-66A5-4152-8D6D-17C175F96DCCQ35224467-9AB052E2-6455-4FD9-A9F3-F1F96AE88B1DQ35224469-7D347BD7-FDA1-4C64-AA81-9174CBBF70CCQ35576471-2448213A-14EE-4F7C-A544-98405C4E260DQ35793230-99C58F4F-62C7-4B5F-92BA-828C8A8C51DEQ35860193-F4C808F2-E3D6-4ADB-9740-BB8D42691DE9Q35979595-6C416657-41D8-4A2D-9A3D-8DF23F69FD5DQ36023165-9D736763-67F2-421A-853C-EABD2245EF9CQ36659002-3393583A-5061-4E99-A102-127AD55AC90BQ36722169-AFD81BF1-47E0-4CF0-9954-954B78EBDB65Q36723250-54F9AFE4-3EBC-4975-9009-760D9C486A04Q36840545-1FC98C14-8E41-4FE5-A175-F5EE5DDDA8DFQ36899649-77A2F245-54B8-409A-AD43-1AC0044DF27DQ36907316-DD81FD20-2E46-4630-8710-1DD2AF62FC13Q36915331-BE44C2BB-A589-4DAC-AC87-3E0C6E7D870AQ37411837-DF316366-ADD2-494F-8B52-627668A79259Q37682213-EDA530BB-3517-4219-81B3-FEFCFFF011C6Q37695129-DD1375BB-865D-46AD-BAEC-F6913FBCBA77Q37873918-1A328627-D1B7-440E-945B-E4E33E8BB149Q38037193-0DF34AD3-005F-478B-8D68-B202C1E03B7BQ38085594-47D15CD1-F1BE-4EC6-BBE4-D2B0108CCBDCQ38172634-F7853706-CC2B-46BF-AC05-F58B289A8852Q38262882-AA32D04F-3832-411E-AFE3-0F5F808E357BQ38431560-851DB8FD-1A97-4F4A-ABAE-B4E2647C3318Q38440153-0CE7226C-C170-42BE-B0CF-20BABF3ECC40Q38479609-352E3DD3-AFC9-46EF-A6C4-E86B2129422FQ38742550-D3CCFE2D-D055-473C-8EA0-8B7CA39DCEA1Q38785743-309B9B4F-9779-46A6-8778-981536D380B7Q38828165-AC117AD0-3775-48AF-8129-413D79AA2785Q38831549-33C7E595-6498-42B1-A4CF-115383DC08F7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gang Zheng
@ast
Gang Zheng
@en
Gang Zheng
@es
Gang Zheng
@nl
Gang Zheng
@sl
type
label
Gang Zheng
@ast
Gang Zheng
@en
Gang Zheng
@es
Gang Zheng
@nl
Gang Zheng
@sl
prefLabel
Gang Zheng
@ast
Gang Zheng
@en
Gang Zheng
@es
Gang Zheng
@nl
Gang Zheng
@sl
P108
P106
P108
P31
P496
0000-0002-0705-7398